Navigation Links
OBN's 2011 Annual Awards Dinner Celebrates UK Bioscience Success Stories
Date:9/14/2011

OXFORD, England, September 14, 2011 /PRNewswire/ --

http://www.obn.org.uk/obn_/menu.php?p=rss&rn=rssfeed&prechk_news=1

Some of the UK's bioscience sector major success stories were recognised last night at the OBN Annual Bioscience Awards Dinner 2011. The not-for-profit business network, which provides comprehensive support for biotech and medtech companies in Oxford and South-East England, celebrated the Awards at a capacity black tie event at Broadgates Hall and Pembroke College, Oxford. The Awards sought to highlight the many great achievements of the UK's bioscience sector in raising funds, making deals and supporting innovation, despite the challenges of operating within an adverse financial climate. This year's Awards had a particular focus on the achievements of the nominees in the current difficult business environment.


The 2011 award winners were:

Circassia,  Best Biotech Fundraiser

Circassia raised £60m for the development of its lead allergy products in April 2011 in the third largest fundraising by a privately-held European biopharmaceutical company in more than 15 years. To date, Circassia has successfully completed four investment rounds, raising approximately £93 million ($159 million).

CellNovo,  Best MedTech Fundraiser

As featured at OBN's 2011 BioTrinity, Cellnovo raised £30m to advance mobile diabetes management in February 2011. Cellnovo is using the funds to commercialize its miniaturised integrated pump, meter and management system and expand to markets around the world.

Vertex Pharmaceuticals,  Best New Product

Incivek™ (telaprevir) is a new oral medicine approved in the USA in May 2011 for the treatment of hepatitis C. It acts directly on the hepatitis C virus protease, an enzyme essential for viral replication. In clinical trials, Incivek has been shown to dramatically reduce the time on HCV therapy for many patients.

Amgen/BioVex,  Best Dealmaker

Amgen completed its acquisition of BioVex in March 2011 in a deal worth up to $1 billion gaining access to its product candidates based around its oncolytic virus therapy for cancer.

Progenitor Labs, Best Emerging biotech

Progenitor Labs is a biotechnology company spun out of Plasticell that is exploiting stem and progenitor cells to design high-throughput screens for the discovery of small molecule therapeutics that regenerate tissues of the human body.

OxTexs,  Best Emerging Medtech

Oxtexs is a manufacturer of anisotropic self-inflating tissue expanders for use in reconstructive plastic surgery and restorative dentistry. For the first time, surgeons will be able to accurately and predictably control the direction, the timing, and rate of the material's expansion in the body. This will significantly reduce the risk of soft tissue damage and associated complications.

Dr Jon Rees, OBN's CEO, said: "It is always a pleasure to have the opportunity to celebrate the real business successes being delivered by our member companies and this year's Awards dinner was no exception. The winners highlight the ongoing strengths of the 'Golden Triangle' of the Oxford, Cambridge and London bioclusters and the impact science-based companies are having across a range of healthcare areas.  This positive news was recently complimented by the announcement of an Enterprise Zone offering incentives to companies locating in the Science Vale region of South Oxfordshire."


**Photographs of the Awards are available on request**


About OBN


OBN is a not-for-profit business network which provides comprehensive support for its member biotech and medtech companies in the Oxford and South-East England biocluster and the rest of the UK. Our activities can be summarised as networking, partnering, group purchasing, and fundraising advice. Through its delivery of Europe's fastest growing biopartnering and investment conference, BioTrinity, OBN generates more R&D-company-to-investor interactions than anyone else in Europe. OBN is sponsored by Shire, as Corporate Patron, and Corporate Sponsors MEPC, Manches LLP, James Cowper, Red Moon Executive Search, SRG, FOCUS Insurance, World Courier and Citigate Dewe Rogerson as well as by its extensive membership of R&D companies and other companies across the entire life sciences industry ecosystem.

Read more news about OBN

Contacts

OBN
Jon Rees, CEO
Tel: +44 (0)7795 233883
jon.rees@obn.org.uk

Citigate Dewe Rogerson
Nina Enegren
Tel: +44 (0) 20 7638 9571
nina.enegren@citigatedr.co.uk



'/>"/>
SOURCE OBN
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008
2. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
3. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
4. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
7. ATS Medical to Participate at the Fourth Annual Noble Financial Equity Conference
8. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
9. 3SBio Inc. to Hold Annual General Meeting
10. Early-Bird Registration Ends this Week for 10th Annual Quality Excellence Conference: How Process Improvement Leaders Produce Profits in Recessions
11. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT ... care circle with the physician and clinical trial team. , Using the CONSULT module, ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. ... the faculty of the University of North Carolina Kenan-Flagler Business School ... entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
Breaking Biology News(10 mins):